Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
1 other identifier
observational
100
1 country
1
Brief Summary
Cardiovascular disease is the most common cause of mortality and morbidity worldwide. Recently, a growing body of evidence has identified Vitamin D deficiency as a potential risk factor for cardiovascular disease. Therefore, there is an increasing interest to explore the mechanism in which vitamin D deficiency affect the cardiovascular system. The investigators want to examine the relationship between serum vitamin D levels and the coagulation status in the subjects. The applied the calibrated automated thrombogram (CAT) to assess thrombin generation in plasma as a measure of overall thrombotic activity, and thus to suggest a mechanism that may explain the link between vitamin D deficiency and cardiovascular disease. Our study population are going to include 100 patients from the internal departments in Emek hospital, who present with chest pain but without acute coronary syndrome (ACS). The investigators will take blood samples from the subjects to measure the serum vitamin D levels and the generation of thrombin. The patients will be divided into four groups according to the level of vitamin D to evaluate the effect of vitamin D levels in the blood on coagulability and thrombotic activity in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2013
CompletedFirst Posted
Study publicly available on registry
February 27, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedMay 6, 2014
February 1, 2013
1 year
February 6, 2013
May 4, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
thrombin generation levels and endogenous thrombin potentials
measuring the thrombin generation and endogenous thrombin potential by the calibrated automated thrombogram (CAT)
4 month
Eligibility Criteria
hospitalized patient
You may qualify if:
- hospitalized patient with diagnosed of chest pain
You may not qualify if:
- recent Myocardial ischemia - (in the last 30 days)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haemek medical center
Afula, 18101, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mazen elias, prof
haemek medical center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2013
First Posted
February 27, 2013
Study Start
April 1, 2013
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
May 6, 2014
Record last verified: 2013-02